id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id FDA-2020-E-2326-0006,FDA,FDA-2020-E-2326,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2024-03-25T04:00:00Z,2024,3,2024-03-25T04:00:00Z,,2024-03-25T22:50:22Z,,0,0,090000648646a0cb FDA-2020-E-2326-0005,FDA,FDA-2020-E-2326,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2024-01-25T05:00:00Z,2024,1,2024-01-25T05:00:00Z,,2024-01-25T14:46:13Z,,0,0,09000064863c1f71 FDA-2020-E-2326-0004,FDA,FDA-2020-E-2326,Letter from FDA CDER to U S Patent and Trademark Office,Other,Letter(s),2022-06-14T04:00:00Z,2022,6,2022-06-14T04:00:00Z,,2022-06-14T17:03:09Z,,0,0,0900006485162e51 FDA-2020-E-2326-0003,FDA,FDA-2020-E-2326,Patent Term Extension letter from FDA CDER to Honorable Drew Hirshfeld,Other,Extension of Time,2021-03-01T05:00:00Z,2021,3,2021-03-01T05:00:00Z,,2021-03-01T16:56:00Z,,0,0,0900006484a578d7 FDA-2020-E-2326-0001,FDA,FDA-2020-E-2326,Letter from U S Patent and Trademark Office,Other,Letter(s),2020-12-22T05:00:00Z,2020,12,2020-12-22T05:00:00Z,,2020-12-22T21:26:26Z,,0,0,09000064849bd2d6 FDA-2020-E-2326-0002,FDA,FDA-2020-E-2326,"Patent Term Extension Application for ROZLYTREK® Patent No 8,673,893",Other,Application,2020-12-22T05:00:00Z,2020,12,2020-12-22T05:00:00Z,,2020-12-22T21:27:34Z,,0,0,09000064849bd2d7